AusPAR: Brentuximab vedotin

Australian Public Assessment Report

AusPAR

AusPAR: Brentuximab vedotin [PDF, 1.44 MB]

AusPAR: Brentuximab vedotin [Word, 3 MB]

Attachment: Product Information: Brentuximab vedotin [PDF, 541.06 KB]

Attachment: Product Information: Brentuximab vedotin [Word, 427.15 KB]

Attachment: Extract from Clinical Evaluation Report Brentuximab vedotin [PDF, 5.32 MB]

Attachment: Extract from Clinical Evaluation Report Brentuximab vedotin [Word, 9.08 MB]

Device/Product Name

Adcetris

Active ingredients

Brentuximab vedotin

AusPAR Date

14 September 2017

Published

11 October 2017

Submission Number

PM-2015-01529-1-4

Submission Type

Extension of indications

Decision

Approved